Silence Therapeutics Plc (SLN.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Sales | 23 | 193 | 263 | 1,078 | 3,652 |
| Operating Expenses | 18,899 | 15,153 | 9,247 | 9,337 | 16,735 |
| Operating Income | -18,875 | -14,960 | -8,983 | -8,260 | -13,083 |
| Interest Expense | N/A | N/A | 0 | 20 | 97 |
| Other Income | 229 | 115 | -33,492 | -627 | -394 |
| Pre-tax Income | -18,646 | -14,844 | -42,475 | -8,907 | -13,574 |
| Income Tax | -1,388 | 0 | 0 | N/A | N/A |
| Net Income Continuous | -17,258 | -14,844 | -42,475 | -8,907 | -13,574 |
| Net Income | $-17,258 | $-14,844 | $-42,475 | $-8,907 | $-13,574 |
| EPS Basic Total Ops | -0.22 | -0.20 | -1.35 | -0.56 | -1.42 |
| EPS Basic Continuous Ops | -0.22 | -0.20 | -1.35 | -0.56 | -1.42 |
| EPS Diluted Total Ops | -0.22 | -0.20 | -1.35 | -0.56 | -1.42 |
| EPS Diluted Continuous Ops | -0.22 | -0.20 | -1.35 | -0.56 | -1.42 |
| EBITDA(a) | $-18,359 | $-14,470 | $-42,068 | $-8,414 | $-12,978 |